Stock Financial Ratios, Dividends, Split History

BATRK / Liberty Media Corporation financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Price22.54
Volume86,600.00
Market Cap ($M)22.13
Enterprise Value ($M)18,578.13
Book Value ($M)16,943.00
Book Value / Share17,256.02
Price / Book0.00
NCAV ($M)-17,659.00
NCAV / Share-17,985.25
Price / NCAV-0.00
Income Statement (mra) ($M)
Revenue7,594.00
EBITDA1,394.00
Net Income1,890.00
Balance Sheet (mrq) ($M)
Cash & Equivalents1,029.00
Cash / Share1,048.01
Assets41,996.00
Liabilities19,422.00
Quick Ratio0.44
Current Ratio0.44
Share Statistics
Common Shares Outstanding239,723,308
Common Shares Outstanding9223,619,199
Common Shares Outstanding310,243,193
Common Shares Outstanding5202,720,256
Common Shares Outstanding42,454,448
Common Shares Outstanding8102,710,302
Common Shares Outstanding981,860
Common Shares Outstanding625,649,445
Common Shares Outstanding79,821,531
Scoring Models
Piotroski F-Score6.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Kaplan-Zingales KZ-IndexN/A
Cash Conversion CycleN/A
Management Effectiveness (mra)
Return on Invested Capital (ROIC)0.06
Return on Assets (ROA)0.06
Return on Equity (ROE)0.16
Identifiers and Descriptors
CUSIP531229888
Central Index Key (CIK)1560385
Industry Groups
SIC 4833 - Television Broadcasting Stations

Split History

Stock splits are used by Liberty Media Corporation to keep share prices within reasonable numbers to encourage investment. If the share price of a security gets too high, a company can perform a stock split by issuing all shareholders an extra share, thereby halving the price of an individual share. If the share price gets too low, companies can do reverse splits. This is common when share prices drop below $1.00 and company's become in danger of being delisted. However, because of the cost, stock splits are not a normal business occurrence.

Coming soon

Peers - Television Broadcasting Stations (4833)

Related Articles

GNCA: Genocea Biosciences Analysis and Research Report

11h - Asif

Overview Genocea Biosciences is a biopharmaceutical company that discovers and develops novel cancer vaccines. The company use its proprietary discovery platform, ATLAS, to recall a patient’s pre-existing CD4+ and CD8+ T cell immune responses to their tumor to identify antigens for inclusion in vaccines that are designed to act through T cell (or cellular) immune responses. The company believe that using ATLAS to identify antigens for inclusion in cancer vaccines could lead to more immunogenic and efficacious cancer vaccines. In September 2017, the company announced a strategic shift to immuno-oncology and a focus on the development of neoantigen cancer vaccines. Currently, all of its research programs and product candidates in active development are at the preclinical stage. The company's most advanced program is its preclinical immuno-oncology program, GEN-009, a neoantigen cancer vaccine. The GEN-009 program uses ATLAS to identify patient neoantigens, or newly formed anti...

AMZN: Amazon.com, Inc Analysis and Research Report

11h - Asif

Overview Amazon.com opened its virtual doors on the World Wide Web in July 1995. The company seek to be Earth’s most customer-centric company. Amazon is guided by four principles: customer obsession rather than competitor focus, passion for invention, commitment to operational excellence, and long-term thinking. In each of its segments, the company serve its primary customer sets, consisting of consumers, sellers, developers, enterprises, and content creators. In addition, the company provide services, such as advertising services and co-branded credit card agreements. Amazon has organized its operations into three segments: North America, International, and Amazon Web Services (“AWS”). These segments reflect the way the Company evaluates its business performance and manages its operations. Additional information on its operating segments and its net sales is contained in Item 8 of Part II, “Financial Statements and Supplementary Data—Note 11—Segment Information.” The compan...

LPCN: Lipocine Inc Analysis and Research Report

2018-04-23 - Asif

Overview Lipocine is a specialty pharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men’s and women’s health. The company's proprietary delivery technologies are designed to improve patient compliance and safety through orally available treatment options. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Lipocine has a portfolio of proprietary product candidates designed to produce favorable pharmacokinetic (“PK”) characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. The company's lead product candidate, TLANDO™, is an oral testosterone replacement therapy (“TRT”) and is currently under review by the United States Food and Drug Administration (“FDA”) with a Prescription Drug User Fee Act (“...

Related News Stories

7 Sports Stocks to Buy Heading Into Summer | InvestorPlace

21h investorplace
Although I’ve always considered the first leg in horse racing’s Triple Crown the unofficial start to summer, it’s also a time for large consumer goods and sports-related businesses to get their products in front of a huge audience, many of them affluent. (39-0)

UPDATE 1-Motor racing-F1 owner in talks over China venture to boost market push - sources

2018-04-13 reuters
BEIJING/LONDON, April 13 (Reuters) - Formula One is in talks with potential Chinese partners to set up a new local venture, four sources have told Reuters, which would help it push deeper into the huge but still nascent China market. (10-0)

Motor racing-F1 owner in talks over China venture to boost market push - sources

2018-04-13 reuters
BEIJING/LONDON, April 13 (Reuters) - Formula One is in talks with potential Chinese partners to set up a new local venture, four sources have told Reuters, which would help it push deeper into the huge but still nascent China market. (10-0)

Motor racing-Formula One extends data-tracking project to eight races

2018-04-11 reuters
LONDON (Reuters) - Formula One has expanded a crowd-tracking project to eight races this season after a trial run at last year’s U.S. Grand Prix in Austin highlighted how many of those attending were more interested in music than motor racing. (7-0)

Defying New F1 Owners, Monaco Grand Prix Keeps Its ‘Grid Girls’ - Bloomberg

2018-04-05 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. (7-0)

CUSIP: 531229888